1naresh

Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1nareshArray
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)

Table 1: Demographic and clinical characteristics of 130 patients with sbAVM embolization
Characteristics No. (%)
Sex 
    Male 78 (60%)
    Female 52 (40%)
Age, y 
    <18 27 (20.77%)
    18–49 100 (76.92%)
    ≥50 3 (2.31%)
Initial presentation 
    Hemorrhage 79 (60.77%)
    Ischemia 11 (8.46%)
    Headache 13 (10%)
    Seizures 20 (15.38%)
    No symptoms 7 (5.38%)

Characteristics	No. (%)
Sex
Male	78 (60%)
Female	52 (40%)
Age, y
<18	27 (20.77%)
18–49	100 (76.92%)
≥50	3 (2.31%)
Initial presentation
Hemorrhage	79 (60.77%)
Ischemia	11 (8.46%)
Headache	13 (10%)
Seizures	20 (15.38%)
No symptoms	7 (5.38%)